Trial intelligence / Profile preview

Omega-3 vs Omega-6 Fatty Acids in Parenteral Nutrition for Sepsis

NCT00142220Phase 4Completed

Sponsor
Universitätsklinikum Greifswald
Start
Jan 2004
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of omega-3 fatty acid in sepsis (2 arms), sponsored by Universitätsklinikum Greifswald. Primary endpoints: Interleukin-6 level in serum and HLA-expression on monocytes. Started Jan 2004; status: completed.

02

Drugs

omega-3 fatty acid
03

Conditions

sepsis

Beyond the preview

Go deeper on NCT00142220.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00142220.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call